Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:53 PM
Study NCT ID:
NCT02688556
Status:
COMPLETED
Last Update Posted:
2022-08-29
First Post:
2016-02-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Sponsor:
Sun Pharmaceutical Industries Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-13
First Submit QC Date:
None
Study First Post Date:
2016-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-13
Results First Submit QC Date:
None
Results First Post Date:
2019-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-26
Last Update Post Date:
2022-08-29
Last Update Post Date Type:
ACTUAL